Clinical trial
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone
NCT00644852 is registered in ClinicalTrials.gov with Johnson & Johnson Taiwan Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone
- Lead sponsor
- Johnson & Johnson Taiwan Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- September 30, 2007
- Enrollment
- 342 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
schizoaffective disorder, schizophrenia